The ubiquitin-protein ligase activity of Hdm2 is inhibited by nucleic acids

被引:16
|
作者
Linares, LK
Scheffner, M
机构
[1] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany
关键词
hdm2; ubiquitin-protein ligase; RNA; p53;
D O I
10.1016/S0014-5793(03)01108-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proto-oncoprotein Hdm2 is a member of the RING finger-type family of ubiquitin-protein ligases E3. The RING finger domain is assumed to mediate the specific interaction of an E3 with its cognate ubiquitin-conjugating enzyme E2, which catalyzes the covalent attachment of ubiquitin to substrate proteins. In addition, the RING finger domain of Hdm2 is involved in Hdm2 homooligomer formation and has the capacity to bind to RNA in a sequence-specific manner. Here we report that interaction with nucleic acids interferes with both Hdm2/Hdm2 complex formation and auto-ubiquitination of Hdm2 in vitro. Furthermore, although binding of Hdm2 to the tumor suppressor p53 is not inhibited by nucleic acids, Hdm2-mediated ubiquitination of p53 is significantly decreased. Taken together, these results provide the first example of an E3 whose activity can be regulated by direct interaction with nucleic acids. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 76
页数:4
相关论文
共 50 条
  • [1] Assay for ubiquitin ligase activity: High-throughput screen for inhibitors of HDM2
    Davydov, IV
    Woods, D
    Safiran, YJ
    Oberoi, P
    Fearnhead, HO
    Fang, S
    Jensen, JP
    Weissman, AM
    Kenten, JH
    Vousden, KH
    JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (08) : 695 - 703
  • [2] Hdm2 is an ubiquitin ligase for the anti-apoptotic protein Ku70
    Gama, Vivian
    Gomez, Jose A.
    Mayo, Lindsey D.
    Haas, Arthur L.
    Matsuyama, Shigemi
    BLOOD, 2007, 110 (11) : 982A - 983A
  • [3] Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
    Yang, YL
    Ludwig, RL
    Jensen, JP
    Pierre, SA
    Medaglia, MV
    Davydov, IV
    Safiran, YJ
    Oberoi, P
    Kenten, JH
    Phillips, AC
    Weissman, AM
    Vousden, KH
    CANCER CELL, 2005, 7 (06) : 547 - 559
  • [4] BINDING-SITES OF UBIQUITIN-PROTEIN LIGASE - BINDING OF UBIQUITIN-PROTEIN CONJUGATES AND OF UBIQUITIN-CARRIER PROTEIN
    REISS, Y
    HELLER, H
    HERSHKO, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (18) : 10378 - 10383
  • [5] Characterization of the Hdm2/HdmX E3 ligase activity
    Iyappan, S.
    Wollscheid, H. P.
    Singh, R. K.
    Tang, H. C.
    Scheffner, M.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2009, 88 : 34 - 34
  • [6] Aurka Regulates Hdm2 E3-Ubiquitin Ligase in Esophageal Adenocarcinoma Cells
    Sehdev, Vikas
    Katsha, Ahmed M.
    Belkhiri, Abbes
    El-Rifai, Wael
    GASTROENTEROLOGY, 2012, 142 (05) : S60 - S60
  • [7] Regulation of HDM2 E3-ubiquitin ligase in esophageal adenocarcinoma cells by AURKA
    Sehdev, Vikas
    Belkhiri, Abbes
    Soutto, Mohammed
    Katsha, Ahmed M.
    El-Rifai, Wael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] MULTIPLE FORMS OF UBIQUITIN-PROTEIN LIGASE - BINDING OF ACTIVATED UBIQUITIN TO PROTEIN SUBSTRATES
    LEE, PL
    MIDELFORT, CF
    MURAKAMI, K
    HATCHER, VB
    BIOCHEMISTRY, 1986, 25 (11) : 3134 - 3138
  • [9] Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2
    Yamanaka, K
    Ishikawa, H
    Megumi, Y
    Tokunaga, F
    Kanie, M
    Rouault, TA
    Morishima, I
    Minato, N
    Ishimori, K
    Iwai, K
    NATURE CELL BIOLOGY, 2003, 5 (04) : 336 - 340
  • [10] The binding of translationally controlled tumour protein to HDM2 is inhibited by Nutlin-3
    Funston, G.
    Goh, W.
    Wei, S.
    Tng, Q.
    Brown, C.
    Tong, L.
    Verma, C.
    Lane, D.
    Ghadessy, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S104 - S105